Copanlisib HCl hydrate

Copanlisib Dihydrochloride is a potent and selective PI3K inhibitor that suppresses the PI3K signaling pathway, leading to the inhibition of proliferation and survival in susceptible cancer cells. It is widely used in oncology research, demonstrating activity in both in vitro assays and in vivo xenograft models for hematological malignancies and solid tumors.